Advantage Alpha Capital Partners LP Xencor Inc Transaction History
Advantage Alpha Capital Partners LP
- $419 Million
- Q3 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Xencor Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 24,861 shares of XNCR stock, worth $603,873. This represents 0.12% of its overall portfolio holdings.
Number of Shares
24,861
Previous 42,871
42.01%
Holding current value
$603,873
Previous $811,000
38.47%
% of portfolio
0.12%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
215Shares Held
71.5MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$270 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$222 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$185 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$129 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$95.4 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.45B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...